why choose us

First received: May 22, 2023

Clinical Trial: Fluvoxamine for Long COVID-19

Study Status: Completed

Recruit Status: RECRUITING

Condition: Long COVID

Study Type: INTERVENTIONAL


Official Title: FLUVOXAMINE AS A TREATMENT FOR LONG COVID-19: A RANDOMIZED PLACEBO CONTROLLED TRIAL

Brief Summary: This clinical trial aims to test the effects of fluvoxamine as a treatment for Long COVID.Fluvoxamine is an FDA approved SSRI for Obsessive Compulsive Disorder (OCD), that has already had success in preventing hospitalization in patients with COVID-19 (STOP COVID and TOGETHER trials).This trial is testing whether fluoxamine helps to improve symptoms and the negative impacts of long COVID in residents of Missouri and Illinois.

Read more